Mikhail Yuryevich Kvasnikov
General Director of Pharmasyntez-Nord
Pharmasyntez-Nord
Pharmasyntez-Nord
A high-tech company covering the full development and manufacturing cycle for biotechnology medicines, monoclonal antibodies, cytostatic and cytotoxic agents to treat cancer, autoimmune and endocrine diseases
.webp&w=3840&q=90)
- 70+
medicines in the company’s product range
- 2010
company established in St. Petersburg
- 2025
launch of the third manufacturing phase project
Management
Strategic management of the company
The company’s expertise covers the full process of creating medicines, from research in its own R&D laboratories to manufacturing in accordance with international GMP requirements.
Key areas of work include the development of monoclonal antibodies, insulin and conjugate technologies, and gene therapy.
At the heart of all this is a team of young scientists, researchers and specialists. Their knowledge, experience and solutions shape the future of Russia’s pharmaceutical industry.
Pharmasyntez-Nord
Therapeutic expertise
Advanced care in key areas
company portfolio69
medicines on the Russian List of Vital and Essential Medicines
14
medicines in the high-cost disease programme
58
anticancer medicines
Manufacturing capabilities
From developing innovative medicines to bringing them into use
- 001
Modern technologies
7 aseptic filling lines using fill-finish and oRABS, with high levels of automation and quality control
- 002
Manufacturing scale
More than 11,000 m² of cleanrooms
- 003
Research and development
One of Russia’s largest biotechnology R&D centres
- 004
Versatility
Manufacturing medicines in various forms: tablets, hard and soft capsules, solutions, concentrates, lyophilisates, cartridges and pre-filled syringes
- 005
International certification
The first Russian pharmaceutical company to receive a GMP certificate from the Brazilian regulator ANVISA for the manufacture of non-sterile dosage forms
Manufacturing infrastructure
Equipment and technological solutions that meet international standards
Company contacts
Send an enquiry or contact us directly
General information
Enquiries about the company, partnerships and general information
Reception
Media enquiries
Journalists’ enquiries, expert comments, interviews and press materials
General company information
Full name: Aktsionernoye obshchestvo “Pharmasyntez-Nord”
Abbreviated name: AO “Pharmasyntez-Nord”
General Director: Mikhail Yuryevich Kvasnikov
Contact information
Telephone/fax: 8 (812) 240-45-15
E-mail: info-psn@pharmasyntez.com
Company addresses
Registered address: premises 1-N, 74, Doroga v Kamenku, St. Petersburg, 197350, Russia
Postal address: PO Box 45, St. Petersburg, 197350, Russia
Operating address: premises 1-N, 74, Doroga v Kamenku, St. Petersburg, 197350, Russia
Registration and identification details
Taxpayer Identification Number (INN): 3851000490
KPP: 781401001
OGRN: 1103851000494
Bank details
Bank name: Tsentralny Branch of VTB Bank (PAO), Moscow
Current account: 40702810508030004299
Correspondent account: 30101810145250000411
Bank Identification Code (BIK): 044525411
.webp&w=3840&q=90)